Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Adenocarcinoma, Clear Cell (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinosarcoma (Phase 1)

Celiac Disease (Phase 2)

Cystadenocarcinoma, Serous (Phase 2)

Endometrial Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Mesothelioma (Phase 2)

Mixed Tumor, Mullerian (Phase 1)

Multiple Myeloma (Phase 1)

Myeloproliferative Disorders (Phase 1)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 1)

Ovarian Neoplasms (Phase 3)

Pancreatic Neoplasms (Phase 1)

Peritoneal Neoplasms (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Small Cell Lung Carcinoma (Phase 2)

Stomach Neoplasms (Phase 2)